ArticleFrontiers in oncology2021

LINC01977 Promotes Breast Cancer Progression and Chemoresistance to Doxorubicin by Targeting miR-212-3p/GOLM1 Axis.

Zheng Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.